Clinical Trials in Pittsburgh

Showing 7061-7080 of 16,007 trials

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

NCT04807595

This is a worldwide, multicenter, non-interventional, retrospective study of patient medical records from metastatic breast cancer (mBC) patients previously identified as human epidermal growth factor receptor 2 negative (HER2-neg), regardless of hormone status.

Breast Cancer

AstraZeneca798 participantsStarted May 2021

Pittsburgh, Pennsylvania, United States • Melbourne, Australia • Montreal, Quebec, Canada +10 more locations

COMPLETEDPhase 2< 1 mile

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

NCT02664558

This proof-of-concept study is designed as a Phase 2, multicenter, randomized, double-blind, placebo controlled study comparing ubenimex with placebo in patients with pulmonary arterial hypertension (PAH) (World Health Organization \[WHO\] Group 1) and have a WHO/New York Heart Association (NYHA) Functional Classification (WHO/NYHA-FC) of II or III.

Pulmonary Arterial Hypertension

Eiger BioPharmaceuticals61 participantsStarted Apr 2016

Birmingham, Alabama, United States • Beverly Hills, California, United States • La Jolla, California, United States +28 more locations

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Find Trials by Condition in Pittsburgh

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

TAC Versus TC for Adjuvant Breast Cancer

Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy

Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge

10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Achieving Diagnostic Excellence Through Prevention and Teamwork